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Abstract: Aim: The purpose of the present study is to summarize and interpret the data, which has been received 
earlier, in order to prove the development of the hibernation of myocardium (HM) in cases of the neuroleptic 
cardiomyopathy (NCMP). 
Methods: Morphometric methods of research were used which meets modern requirements of the evidence based 
medicine. The studied micromorphometric parameters describe the condition of three structural components of 
myocardium (vasculature, intercellular matrix, and parenchyma). Such parameters as zone of pericapillary diffusion 
(ZPD), Kernogan index (KI), Stromal-parenchymatous ratio (SPR), rate of interstitial edema (RIE) were calculated. 
Karyometry and cytometry of cardiomyocytes (CMCs) were performed, the specific volumes of hypertrophied CMCs 
(SVHC), of atrophied CMCs (SVAC) and – by the method of polarization microscopy – the specific volume of dystrophic 
CMCs (SDVC) were determined. 
Results: In the absence of NCMP, the changes, which have an acute character, develop in the case of sudden cardiac 
death (SCD) and malignant neuroleptic syndrome (NMS) and reflect the statistically significant (p<0.05) shifts of the 
respective quantitative parameters. When NCMP is present, the only parameter, which is significantly changed in 
connection with SCD and NMS, is SVDC (p<0.05). 
Conclusion: NCMP causes irreversible damages in myocardium, it leads to its insensitivity, practically almost fully 
prevents it from reacting to any influences, particularly in the presence of SCD and/or development of NMS. The 
morphofunctional state of cardiac muscle in the case of NCMP is an independent proof of state of hibernation of 
myocardium which appears during the process of morphogenesis of NCMP. 
Keywords: Neuroleptic cardiomyopathy, Morphometric research, Hibernation of myocardium, Mann-Whitney  
U-test.  
INTRODUCTION 
The term "hibernating (dormant) myocardium" is 
used to describe a distinctive state of cardiac muscle in 
conditions of its long ischemia [1-4]. When HM is 
present, the metabolic energy processes in cardio- 
myocytes (CMC's) are minimized, the contractility of 
the latter is reduced but their viability is preserved  
[3, 5].  
HM is often observed when different forms of 
coronary heart disease (CHD) [1, 3, 6, 7] including the 
ischemic cardiomyopathy (ICMP) [6] are present, and 
in cases of development of chronic heart failure (CHF) 
[1]. It seems that HM can be considered as a general 
pathologic adaptive process which develops in the 
myocardium when its ischemia of any genesis is 
present [2-5, 7].  
Reports about HM in cases of cardiomyopathies, a 
diabetic cardiomyopathy [8] and idiopathic dilated one 
(DCMP) [9] indeed appeared recently. However there 
are no reports about HM in cases of neuroleptic 
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cardiomyopathy (NCMP) in literature although NCMP 
belongs to specific (secondary) DCMP's [10] as well as 
ICMP, but HM is quite often observed in cases of ICMP 
[6]. It should be said that the clinical course of diseases 
[11, 12], their pathomorphology [13] and pathogenesis, 
which is based on myocardial ischemia, have much in 
common [14, 15].  
We conducted our own morphologic study of heart 
after sudden cardiac death (SCD) had occurred in 
patients with NCMP or malignant neuroleptic syndrome 
(NMS) had developed in them and we found that 
myocardium gets a certain areactivity in cases of 
NCMP and does not react to such acute stress 
situations as SCD and NMS [16-18]. It leads to a 
natural question whether such insensitivity is a sign of 
presence of HM. 
Therefore the aim of the present study is to 
summarize and interpret the data, which have been 
received earlier, in order to prove the development of 
HM in cases of NCMP. 
MATERIALS AND METHODS 
Myocardium of 169 dead persons was studied who 
had schizophrenia (men - 105, women - 64; age from 
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16 to 77 years) and over the period from a half-year to 
30 and more years had received various antipsychotic 
(neuroleptic) drugs (AD) in amounts which correspond 
to the therapeutic standard; these medicines were not 
rarely received in combination with each other. 
Criteria of exclusion: CHD, arterial hypertension, 
heart defects, metabolic syndrome. 
The material of study is divided into the following 
groups (Table 1): I – 20 patients without any heart 
pathology who died of acute non-cardiac causes; II – 
24 patients who had NCMP and died of various 
causes, except SCD; III – 13 patients without NCMP in 
whom SCD was found; IV – 21 patients who had 
NCMP and suddenly died; V – 58 patients in whom 
NCMP was observed, without differentiation of the 
cause of death; VI – 17 lethal cases of NMS without 
concomitant heart diseases; VII – 16 patients who died 
of NMS which had developed in the presence of 
NCMP.  
Analysis of data has been conducted in two 
directions. First, the changes of myocardium micro- 
structure were traced in the cases of SCD and NMS in 
patients without NCMP in comparison with the group I 
(comparison of groups I–III and I–VI). Second, the 
same study was conducted on patients with NCMP 
(comparison of groups II–IV and V–VII). 
Myocardium slices from various departments of the 
left ventricle were filled in paraffin, cuts were painted by 
hematoxylin and eoziny. Respective objects were 
studied in 10 different fields of microscope, with 
necessary magnifications with the help of an ocular 
micrometer, the point count method was also used [19]. 
Such parameters as zone of pericapillary diffusion 
(ZPD), Kernogan index (KI), stromal-parenchymatous 
ratio (SPR) and rate of interstitial edema (RIE) were 
calculated. Karyometry and cytometry of cardiomyo- 
cytes (CMCs) were performed, the specific volumes of 
hypertrophied CMCs, of atrophied ones and – by the 
method of polarization microscopy – the specific 
volume of dystrophic ones were determined. The 
above-named parameters describe a condition of three 
structural components of myocardium: of microvas- 
culature (ZPD and KI), intercellular matrix (SPR and 
RIE), and parenchyma.  
STATISTICAL ANALYSIS 
The received results were statistically processed by 
the nonparametric Mann-Whitney U-test with signify- 
cance level of 5%.  
RESULTS  
In the absence of NCMP, the changes which have 
an acute character, develop in the case of SCD 
(comparison of groups’ I–III) and reflect the statistically 
significant (p<0.05) shifts of the respective quantitative 
parameters: decrease of KI, apparent increase of ZPD, 
RIE and SVDC (Table 2).  
When NCMP is present (comparison of groups II–
IV), the only parameter, which is significantly changed 
in connection with SCD, is SVDC (p<0.05). 
Table 1: Characteristics of the Studied Material 
Groups The Number of Cases NCMP +/– Causes of Death 
I 
APT 20 – Acute non-cardiac causes of death 
II 
NCMP 24 + The different causes of death, except SCD 
III 
SCD 13 – SCD 
IV 
NCMP/SCD 21 + SCD 
V 
NCMP 58 + 
Various acute and chronic diseases, including cardiac pathology 
(SCD, CHF), suicide, etc 
VI 
NMS 17 – NMS 
VII 
NCMP/NMS 16 + NMS 
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Development of NMS is accompanied by 
statistically significant deviations of such parameters as 
ZPD, RIE, SVDC (comparison of groups I–VI). On the 
contrary, the comparison of groups V and VII shows 
that the comorbid pathology (NMS in the presence of 
NCMP) does not cause such apparent damages of 
myocardium microstructure. A reliable negative 
dynamics is observed, like in the cases of SCD, only 
for SVDC (Table 2). 
DISCUSSION 
Myocardium morphology of the patients, who 
received antipsychotic (neuroleptic) drugs (AD) but 
hadn’t NCMP, are strongly affected both by SCD and 
NMS [13, 16, 17, 20, 21].  
After sudden cardiac death the considerable acute 
disturbances of microcirculation in the form of paresis 
of myocardium microvessels are observed, the 
decrease of value of KI is an evidence of it. It causes 
the onset of tissue hypoxia with a subsequent increase 
of permeability of walls of capillary network and with a 
growth of interstitial edema (apparent increase of RIE). 
The edema promotes the disconnection of nutritional 
capillaries and CMC's (growth of ZPD) [22] what 
seriously impairs the trophism of the latter and is a 
cause of a quick development of intracellular dystrophic 
processes (increase of SVDC) [13, 22]. 
The described changes are the material basis of 
electrical instability of myocardium and it is fraught with 
development of severe rhythm disturbances and SCD 
[20, 21, 23]. 
Myocardial injuries in course of NMS are a relatively 
acute process too and are characterized by serious 
disturbances of microcirculation, interstitial edema and 
apparent dystrophic degenerative changes of CMC's. 
Thus when SCD occurs and/or NMS manifests itself 
in mentally ill patients without NCMP, pathomorpho- 
logical changes in myocardium are a standard and 
rather limited set of disturbances of all its structural 
components and these disturbances arise acutely. At 
the same time the reactivity of myocardium is on a 
quite high level. 
NCMP has a leveling influence on the state of 
myocardium in the case of each of the acute 
pathologies which are studied. For example, when 
SCD and/or NMS occur in patients with NCMP, no 
disturbances of microcirculation are observed. One can 
believe that deep changes of microvasculature in the 
case of NCMP, which are the very first to develop 
already in the latent stage of the disease and which 
later on become less important [13, 14], deprive 
myocardium microvessels of the level of reactivity 
which is inherent in them.  
Table 2: Morphometric Indicators of a Myocardium  
Microvasculature Intercellular Matrix Cardiomyocytes 
Groups 
 ZPD KI SPR RIE SVHC SVAC SVDC 
I 
APT 128.5 1.42 10.3 9.8 16.9 8.4 5.7 
II 
NCMP 189.3 1.54 39.2 36.4 37.3 23.6 12.8 
III 
SCD 
176.1* 
р=0.009 
1.27* 
р=0.027 9.1 
34.8* 
р=0.005 15.1 8.6 
28.1* 
р=0.002 
IV 
NCMP/SCD 254.3 1.54 38.7 35.9 29.4 19.5 
63.7** 
р=0.002 
V 
NCMP 246.5 1.62 58.8 60.7 25.8 35.2 25.3 
VI 
NMS 
177.5* 
р=0.006 1.48 7.8 
33.4* 
р=0.005 8.9 7.6 
17.8* 
р=0.004 
VII 
NCMP/NMS 293.6 1.61 
41.6*** 
р=0.01 69.2 23.2 
24.4*** 
р=0.01 
47.6*** 
р=0.01 
Note: APT – antipsychotic therapy 
* – statistically significant distinctions with group I  
** – statistically significant distinctions with group II  
*** – statistically significant distinctions with group V  
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Parameters of state of extracellular matrix (stroma) 
of myocardium don’t have any significant negative 
changes too. The statistically significant difference of 
SPR, which is discovered in the case of NMS in the 
compared groups V-VII, is evidence of a less apparent 
process of sclerosis of myocardium stroma in the case 
of comorbid pathology; this difference has no 
pathogenetic significance for development of 
myocardial injuries in the case of NMS for the following 
reasons.  
It is known that young and middle-aged persons 
(from 20 to 40 years) are more often affected in the 
case of NMS [18, 24]. Therefore the group VII mainly 
includes patients in whom NCMP appeared relatively 
recently, i.e. it is in the latent or full-scale stage. 
Myofibrosis is yet relatively moderately apparent in 
these stages of the disease morphogenesis [13, 14]. 
On the contrary, the group V includes patients with 
NCMP whose stage is not taken into consideration, 
many of them died of CHF in the terminal stage of the 
disease when the development of myofibrosis is 
maximally apparent.  
The above mentioned circumstances also explain 
the decrease of SVAC which is found in cases of 
comorbid course of NMS and NCMP. The only 
parameter of the studied ones, which responds to 
development of such fatal situations as SCD and NMS, 
is SVDC. Its growth in both cases reflect processes of 
severe damage of CMC's and these processes 
inevitably progress in the cases of SCD and/or NMS, 
even in the presence of NCMP. 
Thus the quantitative structural parameters of 
myocardium, whose changes take rather much time 
(SPR, SVHC and SVAC) - and exactly it is observed in 
the process of morphogenesis of NCMP [13, 14] - 
remain without any significant changes when SCD 
occurs and/or NMS develops. At the same time it is 
important to emphasize that such acutely developing 
pathologic processes as disturbances of microcir- 
culation and progression of interstitial edema are not 
apparent in the cases of SCD and/or NMS in 
combination with NCMP either. 
It follows from what has been said that NCMP 
causes irreversible damages in myocardium, it leads to 
its insensitivity, practically almost fully prevents it from 
reacting to any influences, particularly to the coming of 
SCD and/or development of NMS. The found 
morphofunctional state of cardiac muscle in the case of 
NCMP is analogous to HM which has been described 
in cases of ICMP [1-3, 6, 7].  
CONCLUSION 
The conducted morphometric study of changes in 
myocardium develop in cases of SCD and/or NMS in 
patients without NCMP on the one hand, and in the 
presence of the mentioned iatrogenic pathology on the 
other hand, has discovered significant differences. 
When NCMP is present, a considerable decrease of 
reactivity of all studied structural components of cardiac 
muscle is observed, i.e. microvasculature, extracellular 
matrix and CMC's. This fact is an independent proof of 
state of HM which appears during the process of 
morphogenesis of NCMP what has not been so far 
described in literature. 
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